A miRNA composition for predicting chronic hepatitis B inflammatory damage
A technology for chronic hepatitis B and inflammation, applied in the field of medical testing, can solve problems such as unacceptable by patients, and achieve the effect of improving accuracy
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0027] Example 1 Screening of chronic hepatitis B inflammatory injury-related miRNA
[0028] Using a four-step screening method:
[0029] (1) In the discovery stage, we used the next-generation deep sequencing technology (IlluminaHiseq 2000) to detect the mixed samples of the discovery set, found miRNAs with differential expression, and selected 6 cases with mild and moderate inflammation and necrosis respectively;
[0030] (2) In the screening stage, use qRT-PCR method to select internal reference miRNA, establish a uniform small number of cohort screening sets, measure the cycle number (Ct) by 2-△△Ct, and eliminate miRNACt value75%; For miRNAs with p<0.05, 20 cases were selected for mild and moderate inflammation and necrosis respectively;
[0031] (3) In the training stage, the target miRNAs selected in the training and screening stage were tested by using qRT-PCR on a large sample training set (136 cases of mild and 201 cases of moderate inflammation and necrosis respecti...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com